Facioscapulohumeral Muscular Dystrophy clinical trials at University of California Health
3 in progress, 1 open to eligible people
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD)
open to all eligible people
The primary goal of this proposal is to collect motor and functional outcomes specific to FSHD over time. By collecting measures specific to FSHD, this will help ensure the best level of clinical care is being provided. Also, the hope is to speed up …
at UCLA
AOC 1020 in Participants With Facioscapulohumeral Muscular Dystrophy (FSHD)
Sorry, in progress, not accepting new patients
A Randomized, Double-blind, Placebo-controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Exploratory Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral…
at UCLA UCSD
AOC 1020 in Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
Sorry, accepting new patients by invitation only
A Phase 2 Open-label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of AOC 1020 Administered Intravenously to Participants with Facioscapulohumeral Muscular Dystrophy (FSHD)
at UCLA UCSD
Our lead scientists for Facioscapulohumeral Muscular Dystrophy research studies include Perry Shieh, MD, PhD.
Last updated: